(Q70187509)
Statements
Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial (English)
R O Dillman
R K Oldham
N M Barth
R J Cohen
D R Minor
R Birch
J R Yannelli
J R Maleckar
A Sferruzza